{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:39:37Z","timestamp":1790401177230,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T00:00:00Z","timestamp":1621382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T00:00:00Z","timestamp":1621382400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"This work was partly supported by the University of Calgary and the Catholic University of Health and Allied Sciences to JS as part of his PhD training","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"name":"The Calgary Laboratory Services, Calgary, AB.","award":["10015169"],"award-info":[{"award-number":["10015169"]}]},{"name":"The University of Calgary Research Seed Grant","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"DOI":"10.1007\/s10096-021-04271-w","type":"journal-article","created":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T10:02:52Z","timestamp":1621418572000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["The importance of Escherichia coli clonal complex 10 and ST131 among Tanzanian patients on antimicrobial resistance surveillance programs"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2420-5329","authenticated-orcid":false,"given":"Jeremiah","family":"Seni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisele","family":"Peirano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen E.","family":"Mshana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann D. D.","family":"Pitout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebekah","family":"DeVinney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,19]]},"reference":[{"key":"4271_CR1","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S1473-3099(08)70041-0","volume":"8","author":"JD Pitout","year":"2008","unstructured":"Pitout JD, Laupland KB (2008) Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 8:159\u2013166","journal-title":"Lancet Infect Dis"},{"key":"4271_CR2","volume-title":"Prioritization of pathogens to guide discovery, research, and development of new antibiotics for drug resistant bacterial infections, including tuberculosis","author":"WHO","year":"2017","unstructured":"WHO (2017) Prioritization of pathogens to guide discovery, research, and development of new antibiotics for drug resistant bacterial infections, including tuberculosis. The World Health Organization, Geneva http:\/\/www.who.int\/medicines\/areas\/rational_use\/prioritization-of-pathogens\/en\/"},{"key":"4271_CR3","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/nrmicro818","volume":"2","author":"JB Kaper","year":"2004","unstructured":"Kaper JB, Nataro JP, Mobley HL (2004) Pathogenic Escherichia coli. Nat Rev Microbiol 2:123\u2013140","journal-title":"Nat Rev Microbiol"},{"key":"4271_CR4","first-page":"615","volume":"71","author":"AP Dale","year":"2015","unstructured":"Dale AP, Woodford N (2015) Extra-intestinal pathogenic Escherichia coli (ExPEC): disease, carriage and clones. J Inf Secur 71:615\u2013626","journal-title":"J Inf Secur"},{"key":"4271_CR5","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1128\/JCM.43.2.745-749.2005","volume":"43","author":"B Blomberg","year":"2005","unstructured":"Blomberg B, Jureen R, Manji KP, Tamim BS, Mwakagile DS et al (2005) High rate of fatal cases of pediatric septicemia caused by gram-negative bacteria with extended-spectrum beta-lactamases in Dar es Salaam, Tanzania. J Clin Microbiol 43:745\u2013749","journal-title":"J Clin Microbiol"},{"key":"4271_CR6","doi-asserted-by":"publisher","first-page":"e0171216","DOI":"10.1371\/journal.pone.0171216","volume":"12","author":"ME Flokas","year":"2017","unstructured":"Flokas ME, Karanika S, Alevizakos M, Mylonakis E (2017) Prevalence of ESBL-producing Enterobacteriaceae in pediatric bloodstream infections: a systematic review and meta-analysis. PLoS One 12:e0171216","journal-title":"PLoS One"},{"key":"4271_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/zph.12387","volume":"65","author":"J Seni","year":"2018","unstructured":"Seni J, Moremi N, Matee M, van der Meer F, DeVinney R et al (2018) Preliminary insights into the occurrence of similar clones of extended-spectrum beta-lactamase-producing bacteria in humans, animals and the environment in Tanzania: a systematic review and meta-analysis between 2005 and 2016. Zoonoses Public Health 65:1\u201310","journal-title":"Zoonoses Public Health"},{"key":"4271_CR8","doi-asserted-by":"publisher","first-page":"179","DOI":"10.4161\/viru.27045","volume":"5","author":"AG Randolph","year":"2014","unstructured":"Randolph AG, McCulloh RJ (2014) Pediatric sepsis: important considerations for diagnosing and managing severe infections in infants, children, and adolescents. Virulence 5:179\u2013189","journal-title":"Virulence"},{"issue":"Suppl 1A","key":"4271_CR9","doi-asserted-by":"publisher","first-page":"5S","DOI":"10.1016\/S0002-9343(02)01054-9","volume":"113","author":"B Foxman","year":"2002","unstructured":"Foxman B (2002) Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med 113(Suppl 1A):5S\u201313S","journal-title":"Am J Med"},{"key":"4271_CR10","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1471-2334-7-43","volume":"7","author":"B Blomberg","year":"2007","unstructured":"Blomberg B, Manji KP, Urassa WK, Tamim BS, Mwakagile DS et al (2007) Antimicrobial resistance predicts death in Tanzanian children with bloodstream infections: a prospective cohort study. BMC Infect Dis 7:43","journal-title":"BMC Infect Dis"},{"key":"4271_CR11","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1080\/00365540410021045","volume":"37","author":"B Blomberg","year":"2005","unstructured":"Blomberg B, Olsen BE, Hinderaker SG, Langeland N, Gasheka P et al (2005) Antimicrobial resistance in urinary bacterial isolates from pregnant women in rural Tanzania: implications for public health. Scand J Infect Dis 37:262\u2013268","journal-title":"Scand J Infect Dis"},{"key":"4271_CR12","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1128\/JCM.02562-14","volume":"53","author":"M Doumith","year":"2015","unstructured":"Doumith M, Day M, Ciesielczuk H, Hope R, Underwood A et al (2015) Rapid identification of major Escherichia coli sequence types causing urinary tract and bloodstream infections. J Clin Microbiol 53:160\u2013166","journal-title":"J Clin Microbiol"},{"issue":"1554","key":"4271_CR13","first-page":"e1551-1554","volume":"26","author":"MS Holland","year":"2020","unstructured":"Holland MS, Nobrega D, Peirano G, Naugler C, Church DL et al (2020) Molecular epidemiology of Escherichia coli causing bloodstream infections in a centralized Canadian region: a population-based surveillance study. Clin Microbiol Infect 26(1554):e1551-1554\u2013e1551e1558","journal-title":"Clin Microbiol Infect"},{"key":"4271_CR14","doi-asserted-by":"publisher","unstructured":"Pitout JDD, DeVinney R (2017) Escherichia coli ST131: a multidrug-resistant clone primed for global domination. F1000Res. 2017 Feb 28;6:F1000 Faculty Rev-195. https:\/\/doi.org\/10.12688\/f1000research.10609.1","DOI":"10.12688\/f1000research.10609.1"},{"key":"4271_CR15","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3389\/fcimb.2020.00125","volume":"10","author":"SC Flament-Simon","year":"2020","unstructured":"Flament-Simon SC, Garcia V, Duprilot M, Mayer N, Alonso MP et al (2020) High prevalence of ST131 subclades C2-H30Rx and C1-M27 among extended-spectrum beta-lactamase-producing Escherichia coli causing human extraintestinal infections in patients from two hospitals of Spain and France during 2015. Front Cell Infect Microbiol 10:125","journal-title":"Front Cell Infect Microbiol"},{"key":"4271_CR16","doi-asserted-by":"crossref","unstructured":"Manges AR, Geum HM, Guo A, Edens TJ, Fibke CD et al (2019) Global extraintestinal pathogenic Escherichia coli (ExPEC) lineages. Clin Microbiol Rev 32","DOI":"10.1128\/CMR.00135-18"},{"key":"4271_CR17","doi-asserted-by":"publisher","unstructured":"Tchesnokova V, Avagyan H, Billig M, Chattopadhyay S, Aprikian P, Chan D, Pseunova J, Rechkina E, Riddell K, Scholes D, Fang FC, Johnson JR, Sokurenko EV (2016) A novel 7-single nucleotide polymorphism-based clonotyping test allows rapid prediction of antimicrobial susceptibility of extraintestinal Escherichia coli directly from urine specimens. Open Forum Infect Dis. 2016 Jan 18;3(1):ofw002. https:\/\/doi.org\/10.1093\/ofid\/ofw002.","DOI":"10.1093\/ofid\/ofw002"},{"issue":"1","key":"4271_CR18","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.diagmicrobio.2018.04.001","volume":"92","author":"J Seni","year":"2018","unstructured":"Seni J, Peirano G, Okon KO, Jibrin YB, Mohammed A, Mshana SE, DeVinney R, Pitout JDD (2018) The population structure of clinical extra-intestinal Escherichia coli in a teaching hospital from Nigeria. Diagn Microbiol Infect Dis 92(1):46\u201349. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2018.04.001","journal-title":"Diagn Microbiol Infect Dis"},{"key":"4271_CR19","doi-asserted-by":"publisher","unstructured":"Matsumura Y, Pitout JDD, Peirano G, DeVinney R, Noguchi T, Yamamoto M, Gomi R, Matsuda T, Nakano S, Nagao M, Tanaka M, Ichiyama S (2017) Rapid identification of different Escherichia coli sequence type 131 clades. Antimicrob Agents Chemother 61(8):e00179\u201317. https:\/\/doi.org\/10.1128\/AAC.00179-17","DOI":"10.1128\/AAC.00179-17"},{"key":"4271_CR20","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.jgar.2018.12.024","volume":"17","author":"J Seni","year":"2019","unstructured":"Seni J, Tito JN, Makoye SJ, Mbena H, Alfred HS et al (2019) Multicentre evaluation of significant bacteriuria among pregnant women in the cascade of referral healthcare system in North-western Tanzania: bacterial pathogens, antimicrobial resistance profiles and predictors. J Glob Antimicrob Resist 17:173\u2013179","journal-title":"J Glob Antimicrob Resist"},{"key":"4271_CR21","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12887-019-1411-0","volume":"19","author":"J Seni","year":"2019","unstructured":"Seni J, Mwakyoma AA, Mashuda F, Marando R, Ahmed M et al (2019) Deciphering risk factors for blood stream infections, bacteria species and antimicrobial resistance profiles among children under five years of age in North-Western Tanzania: a multicentre study in a cascade of referral health care system. BMC Pediatr 19:32","journal-title":"BMC Pediatr"},{"key":"4271_CR22","volume-title":"Color atlas and textbook of diagnostic microbiology","author":"EW Koneman","year":"1997","unstructured":"Koneman EW, Allen SD, Janda WM, Schreckenberger PC, Winn WC (1997) Color atlas and textbook of diagnostic microbiology, 5th edn. Lippincott. Williams & Wilkins. USA, Philadelphia, Pa","edition":"5"},{"key":"4271_CR23","doi-asserted-by":"publisher","first-page":"154","DOI":"10.4314\/thrb.v11i3.47704","volume":"11","author":"A Masinde","year":"2009","unstructured":"Masinde A, Gumodoka B, Kilonzo A, Mshana SE (2009) Prevalence of urinary tract infection among pregnant women at Bugando Medical Centre, Mwanza, Tanzania. Tanzan J Health Res 11:154\u2013159","journal-title":"Tanzan J Health Res"},{"key":"4271_CR24","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1824-7288-39-27","volume":"39","author":"A Christopher","year":"2013","unstructured":"Christopher A, Mshana SE, Kidenya BR, Hokororo A, Morona D (2013) Bacteremia and resistant gram-negative pathogens among under-fives in Tanzania. Ital J Pediatr 39:27","journal-title":"Ital J Pediatr"},{"key":"4271_CR25","unstructured":"CLSI (2015) Perfomance standards for antimicrobial susceptibility testing; twenty-fifth information supplement. CLSI document M100-S25 (ISBN 1-56238-990-4). Clinical and Laboratory Standards Institute. 950 West Valley Road, Suit 2500, Wayne, Pennsylvania19087. USA."},{"issue":"Suppl 1","key":"4271_CR26","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/j.1469-0691.2007.01846.x","volume":"14","author":"L Drieux","year":"2008","unstructured":"Drieux L, Brossier F, Sougakoff W, Jarlier V (2008) Phenotypic detection of extended-spectrum beta-lactamase production in Enterobacteriaceae: review and bench guide. Clin Microbiol Infect 14(Suppl 1):90\u2013103","journal-title":"Clin Microbiol Infect"},{"key":"4271_CR27","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.1128\/AAC.05824-11","volume":"56","author":"JR Johnson","year":"2012","unstructured":"Johnson JR, Urban C, Weissman SJ, Jorgensen JH, Lewis JS 2nd et al (2012) Molecular epidemiological analysis of Escherichia coli sequence type ST131 (O25:H4) and blaCTX-M-15 among extended-spectrum-beta-lactamase-producing E. coli from the United States, 2000 to 2009. Antimicrob Agents Chemother 56:2364\u20132370","journal-title":"Antimicrob Agents Chemother"},{"key":"4271_CR28","doi-asserted-by":"publisher","first-page":"3736","DOI":"10.1128\/AAC.48.10.3736-3742.2004","volume":"48","author":"V Leflon-Guibout","year":"2004","unstructured":"Leflon-Guibout V, Jurand C, Bonacorsi S, Espinasse F, Guelfi MC et al (2004) Emergence and spread of three clonally related virulent isolates of CTX-M-15-producing Escherichia coli with variable resistance to aminoglycosides and tetracycline in a French geriatric hospital. Antimicrob Agents Chemother 48:3736\u20133742","journal-title":"Antimicrob Agents Chemother"},{"key":"4271_CR29","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1128\/AEM.06663-11","volume":"78","author":"SJ Weissman","year":"2012","unstructured":"Weissman SJ, Johnson JR, Tchesnokova V, Billig M, Dykhuizen D et al (2012) High-resolution two-locus clonal typing of extraintestinal pathogenic Escherichia coli. Appl Environ Microbiol 78:1353\u20131360","journal-title":"Appl Environ Microbiol"},{"key":"4271_CR30","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1128\/AAC.01025-12","volume":"57","author":"S Adams-Sapper","year":"2013","unstructured":"Adams-Sapper S, Diep BA, Perdreau-Remington F, Riley LW (2013) Clonal composition and community clustering of drug-susceptible and -resistant Escherichia coli isolates from bloodstream infections. Antimicrob Agents Chemother 57:490\u2013497","journal-title":"Antimicrob Agents Chemother"},{"key":"4271_CR31","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1093\/cid\/cit503","volume":"57","author":"A Colpan","year":"2013","unstructured":"Colpan A, Johnston B, Porter S, Clabots C, Anway R et al (2013) Escherichia coli sequence type 131 (ST131) subclone H30 as an emergent multidrug-resistant pathogen among US veterans. Clin Infect Dis 57:1256\u20131265","journal-title":"Clin Infect Dis"},{"issue":"8","key":"4271_CR32","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1101\/gr.216606.116","volume":"27","author":"T Kallonen","year":"2017","unstructured":"Kallonen T, Brodrick HJ, Harris SR, Corander J, Brown NM, Martin V, Peacock SJ, Parkhill J (2017) Systematic longitudinal survey of invasive Escherichia coli in England demonstrates a stable population structure only transiently disturbed by the emergence of ST131. Genome Res 27(8):1437\u20131449. https:\/\/doi.org\/10.1101\/gr.216606.116","journal-title":"Genome Res"},{"key":"4271_CR33","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1128\/AAC.01338-09","volume":"54","author":"G Peirano","year":"2010","unstructured":"Peirano G, Richardson D, Nigrin J, McGeer A, Loo V et al (2010) High prevalence of ST131 isolates producing CTX-M-15 and CTX-M-14 among extended-spectrum-beta-lactamase-producing Escherichia coli isolates from Canada. Antimicrob Agents Chemother 54:1327\u20131330","journal-title":"Antimicrob Agents Chemother"},{"key":"4271_CR34","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1111\/j.1469-0691.2011.03518.x","volume":"17","author":"SE Mshana","year":"2011","unstructured":"Mshana SE, Imirzalioglu C, Hain T, Domann E, Lyamuya EF et al (2011) Multiple ST clonal complexes, with a predominance of ST131, of Escherichia coli harbouring blaCTX-M-15 in a tertiary hospital in Tanzania. Clin Microbiol Infect 17:1279\u20131282","journal-title":"Clin Microbiol Infect"},{"key":"4271_CR35","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13756-016-0117-4","volume":"5","author":"T Sonda","year":"2016","unstructured":"Sonda T, Kumburu H, van Zwetselaar M, Alifrangis M, Lund O et al (2016) Meta-analysis of proportion estimates of extended-spectrum-beta-lactamase-producing Enterobacteriaceae in East Africa hospitals. Antimicrob Resist Infect Control 5:18","journal-title":"Antimicrob Resist Infect Control"},{"key":"4271_CR36","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1128\/CMR.00125-13","volume":"27","author":"MH Nicolas-Chanoine","year":"2014","unstructured":"Nicolas-Chanoine MH, Bertrand X, Madec JY (2014) Escherichia coli ST131, an intriguing clonal group. Clin Microbiol Rev 27:543\u2013574","journal-title":"Clin Microbiol Rev"},{"key":"4271_CR37","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13756-018-0361-x","volume":"7","author":"T Sonda","year":"2018","unstructured":"Sonda T, Kumburu H, van Zwetselaar M, Alifrangis M, Mmbaga BT et al (2018) Whole genome sequencing reveals high clonal diversity of Escherichia coli isolated from patients in a tertiary care hospital in Moshi, Tanzania. Antimicrob Resist Infect Control 7:72","journal-title":"Antimicrob Resist Infect Control"},{"key":"4271_CR38","doi-asserted-by":"publisher","first-page":"927","DOI":"10.2147\/IDR.S153601","volume":"11","author":"E Guiral","year":"2018","unstructured":"Guiral E, Pons MJ, Vubil D, Mari-Almirall M, Sigauque B et al (2018) Epidemiology and molecular characterization of multidrug-resistant Escherichia coli isolates harboring blaCTX-M group 1 extended-spectrum beta-lactamases causing bacteremia and urinary tract infection in Manhica, Mozambique. Infect Drug Resist 11:927\u2013936","journal-title":"Infect Drug Resist"},{"key":"4271_CR39","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s12879-016-1527-x","volume":"16","author":"SE Mshana","year":"2016","unstructured":"Mshana SE, Falgenhauer L, Mirambo MM, Mushi MF, Moremi N et al (2016) Predictors of blaCTX-M-15 in varieties of Escherichia coli genotypes from humans in community settings in Mwanza, Tanzania. BMC Infect Dis 16:187","journal-title":"BMC Infect Dis"},{"key":"4271_CR40","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.diagmicrobio.2010.11.011","volume":"69","author":"G Peirano","year":"2011","unstructured":"Peirano G, van Greune CH, Pitout JD (2011) Characteristics of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli from community hospitals in South Africa. Diagn Microbiol Infect Dis 69:449\u2013453","journal-title":"Diagn Microbiol Infect Dis"},{"key":"4271_CR41","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1093\/jac\/dkv017","volume":"70","author":"Y Matsumura","year":"2015","unstructured":"Matsumura Y, Johnson JR, Yamamoto M, Nagao M, Tanaka M et al (2015) CTX-M-27- and CTX-M-14-producing, ciprofloxacin-resistant Escherichia coli of the H30 subclonal group within ST131 drive a Japanese regional ESBL epidemic. J Antimicrob Chemother 70:1639\u20131649","journal-title":"J Antimicrob Chemother"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-021-04271-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-021-04271-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-021-04271-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,27]],"date-time":"2022-12-27T22:01:09Z","timestamp":1672178469000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-021-04271-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,19]]},"references-count":41,"alternative-id":["4271"],"URL":"https:\/\/doi.org\/10.1007\/s10096-021-04271-w","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,19]]},"assertion":[{"value":"6 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the joint CUHAS\/BMC Research and Ethics Committee (CREC 123\/2016) in Tanzania. Permission to conduct the study in various health care facilities was sought and provided by relevant authorities in Tanzania. All patient information were kept confidential and results on antimicrobial susceptibility testing (AST) were timely reported to the attending doctors for specific management based on the respective health care facility treatment guidelines. Voluntary written informed consent to participate was obtained from every pregnant woman (or from children\u2019s parent\/guardian) prior to being involved in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All pregnant women (or children\u2019s parent\/guardian) gave voluntary consent to publish study findings anonymously.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}